Welcome
Support Centre
06 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Epidural steroid injection in chronic lumbar back pain: a cross-over, single-blinded study of methyl-prednisolone 80mg versus methyl-prednisolone 40mg
ISRCTN ISRCTN43299460
ClinicalTrials.gov identifier
Public title Epidural steroid injection in chronic lumbar back pain: a cross-over, single-blinded study of methyl-prednisolone 80mg versus methyl-prednisolone 40mg
Scientific title
Acronym N/A
Serial number at source N0192187922
Study hypothesis Does 40mg of epidural methyl-prednisolone produce an equivalent improvement in disability scores when compared to 80mg of epidural methyl-prednisolone?
Ethics approval Not provided at time of registration
Study design Randomised, single-blinded, cross-over trial
Countries of recruitment United Kingdom
Disease/condition/study domain Musculoskeletal Diseases: Low back pain
Participants - inclusion criteria Patients attending Nottingham City Hospital Day Case Unit, with chronic back pain who are presenting for repeat epidural steroid injection as part of their chronic pain management programme.
Participants - exclusion criteria Blood clotting disorder, anticoagulant (Warfarin) use.
Anticipated start date 24/05/2006
Anticipated end date 28/02/2007
Status of trial Completed
Patient information material
Target number of participants 60
Interventions Randomised, single-blinded, cross-over trial with two treatment arms:
1. 80mg methyl-prednisolone repeated three months later with 40mg dose
2. 40mg methyl-prednisolone repeated three months later with 80mg dose
Primary outcome measure(s) Evidence that a reduced dose of methyl-prednisolone given epidurally does not cause a significant worsening of the primary outcome measure ie the Oswestry Low Back Pain Disability Index.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Nottingham University Hospitals NHS Trust
NHS R&D Support Funding
Trial website
Publications
Contact name Dr  A  Ravenscroft
  Address Anesthetics Department
City Hospital
Hucknall Road
  City/town Nottingham
  Zip/Postcode NG5 1PB
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 28/09/2007
Last edited 25/10/2007
Date ISRCTN assigned 28/09/2007
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central